FAPO-X: Assisted Digital Telemonitoring With Wearables in Patients After Cardiovascular Surgery

NACompletedINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

February 17, 2023

Primary Completion Date

May 23, 2023

Study Completion Date

May 23, 2023

Conditions
Heart; Surgery, Heart, Functional Disturbance as Result
Interventions
DEVICE

Wearable: Smartwatch

The SAMSUNGTM Galaxy Watch5 Smartwatch, is a new generation of smartwatches, features an innovative 3-in-1 BioActive sensor, which uses a chip to capture optical and read cardiac electrical current, allowing to carry out high-quality real-time single-lead electrocardiogram. Despite the more compact design, there is no decrease in accuracy. These signals are then processed by the device's algorithms and can be sent to a trained professional for evaluation immediately after the measurement, facilitating the monitoring and diagnosis of arrhythmias.

Trial Locations (1)

05403-900

Instituto do Coracao (Heart Institute), Faculdade de Medicina, Hospital das Clinicas, Universidade de Sao Paulo, São Paulo

All Listed Sponsors
collaborator

Samsung Electronics

INDUSTRY

lead

University of Sao Paulo

OTHER